AFLD 2014 FFA vs Respondent M70

Facts
The French Athletics Federation (Fédération Française d'Athlétisme, FFA) charges respondent M70 for a violation of the Anti-Doping Rules. During an athletic event on May 11, 2014, a sample was taken for doping test purposes. Analysis of the sample showed the presence of methylhexaneamine which is a prohibited substance according the World Anti-Doping Agency (WADA) 2014 prohibited list. It is regarded as a specified substance.

History
The disciplinary committee of the FFA had sanctioned the respondent with a period of ineligibility lasting six months. The respondent claimed that the positive test derived from a supplement he used. The reason for using the supplement was not to enhance his sport performance, the reason was to loose weight and to treat his chronic tendinitis. However the athlete stays responsible for the supplements he uses and has to check them for not having prohibited substances.

Decision
1. The sanction is a period of ineligibility lasting 9 months in which he can not take part in competition or other manifestations of the FFA and related French sport federations.
2. The period of ineligibility will be reduced by the period already fulfilled by the decision of the disciplinary committee of the FFA.
3. The decision starts on the date of the notification.
4. The decision will be published and sent to the parties involved.

Original document

Parameters

Legal Source
National Decisions
Date
3 December 2014
Original Source
French Anti-Doping Agency (AFLD)
Country
France
Language
French
ADRV
Adverse Analytical Finding / presence
Legal Terms
No intention to enhance performance
Period of ineligibility
Sport/IFs
Athletics (WA) - World Athletics
Other organisations
Agence Française de Lutte contre le Dopage (AFLD) - French Anti-Doping Agency
Fédération française d'athlétisme (FFA) - French Athletics Federation
Laboratories
Paris, France: Agence Française de Lutte contre le Dopage (AFLD)
Doping classes
S6. Stimulants
Substances
4-Methylhexan-2-amine (methylhexaneamine, 1,3-dimethylamylamine, 1,3 DMAA)
Medical terms
Treatment / self-medication
Various
Supplements
Document type
Pdf file
Date generated
17 August 2015
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin